Integrin Receptor Antagonists

Integrin receptor antagonists are a therapeutic class of agents, primarily monoclonal antibodies and targeted synthetic molecules, that inhibit cell-surface integrin heterodimers involved in cellular adhesion, signaling, and trafficking

Integrin receptor antagonists are a therapeutic class of agents, primarily monoclonal antibodies and targeted synthetic molecules, that inhibit cell-surface integrin heterodimers involved in cellular adhesion, signaling, and trafficking By disrupting interactions between integrins and their vascular or extracellular matrix ligands, these medications prevent circulating leukocytes or platelets from adhering and migrating into inflamed tissues or forming pathogenic thrombi Clinically, members of t...

Integrin receptor antagonists are a therapeutic class of agents, primarily monoclonal antibodies and targeted synthetic molecules, that inhibit cell-surface integrin heterodimers involved in cellular adhesion, signaling, and trafficking By disrupting interactions between integrins and their vascular or extracellular matrix ligands, these medications prevent circulating leukocytes or platelets from adhering and migrating into inflamed tissues or forming pathogenic thrombi

Clinically, members of this class are predominantly utilized to treat autoimmune and inflammatory conditions, including inflammatory bowel disease—specifically Crohn's disease and ulcerative colitis—and multiple sclerosis, as well as selected cardiovascular conditions requiring antiplatelet therapy